14:37

Stat para, esti, CR, nonlinearity at optimum,sensitivity analysis,optimal design,population modeling

12:24

Computers in R&D: Gen overview, computer history, statistical modeling: Descriptive v/s mechanistic

13:37

QbD in P'ceutical Development: Intro, ICH Q8 guidelines, regulatory & industry views, scientific app

09:55

Active transport: P-gp. BCRP, nucleoside, hPEPTI, ASBT, OCT, ОАТР, ВВВ- choline transporters #cadd

10:52

Computational Modeling of Drug Disposition:Intro, modeling tech, ADE, sol , intestinal permeation

17:16

CA Formulation Development:optimization, para,tech,FD&screening des, dev p'ceutical emulsions,micro

02:59

Cosmetics Regulatory: Loan license #cosmetics #cosmeceuticals #yt #youtube #mpharm #pharmacy #pharma

01:32

Cosmetics Regulatory: Prohibition of manufacture and sale of certain cosmetics #cosmetics #youtube

13:05

Legal protection of innovative uses of computers in R&D, The ethics in research, in market analysis.

05:13

Cosmetics Regulatory:Regulatory provisions relating to manufacturer&Conditions for obtaining license

01:55

Cosmetics Regulatory: Misbranded and spurious cosmetics #cosmetics #yt #youtube #cosmeceutical #cos

06:26

Cosmetics Regulatory: Regulatory provisions relating to import of cosmetics | Rule 134A | Offences

23:03

CDM:Types of data collection system, communication, regulation of computer system , 21 CFR part 11

03:54

Cosmetics Regulatory: Indian regulatory requirements for labeling of cosmetics #cosmetics #cosmetic

01:40

Cosmetics Regulatory: Offences and penalties related to import & manufacture of cosmetics #cosmetics

02:44

Cosmetics Regulatory: Def of cosmetic products as per Indian regulation and intro to cosmeceuticals

12:47

Computers in Clinical Development: Clinical data collection & management #cadd #mpharmacy #ytshorts

07:42

Gen overview, apps, ad&disad, current challenges & future directions of Computational Fluid Dynamics

04:16

Gen overview, goals, p'ceutical applications,advantages & disadvantages of Pharmaceutical Automation

03:59

General overview, applications, advantages&disad, current challenges & future directions of Robotics

05:06

Gen overview, apps, ad&disad, current challenges & future directions of Artificial Intelligence (AI)

10:51

Computer Simulations in PK&PD:Intro, Whole organism, isolated tissues, organs, cell, proteins&genes.

01:01

Darshan Raval sir's concert @Lloyd College,Greater Noida #darshanraval #darshan #lloyd #lloydcollege

01:57

Correlation: Definition, Karl Pearson’s coefficient of correlation, Multiple correlation #themedico

02:07

Measures of dispersion: Dispersion, Range, standard deviation, variance & mean deviation #themedico

05:35

Measures of central tendency: Mean, Median, Mode #biostatistics #themedico #themedicogirl #stats #yt

06:15

Introduction: Statistics, Biostatistics, Frequency distribution #biostats #themedico #themedicogirl

03:32

Parametric test: t-test(Sample, Pooled or Unpaired and Paired), ANOVA, (1&2 way), LSD #biostatistics

15:33

Regression: fitting,Multiple regression, standard error of regression,Probability:types,Sampling #yt

15:45

DTM: Sample size deter & power of study, report writing , protocol, studies, designing ct & phases.

07:21

Graphs: Histogram, Pie Chart, Line graph, Cubic Graph, Response surface plot, Counter Plot graph #yt

07:03

Intro to Research: Need, Need for design of Experiments, Experiential Design Technique, plagiarism

09:34

CDSCO(India)& PV:D&C Act, Schedule Y,Differences in Indian and global pv requirements #pv #themedico

02:49

CIOMS: CIOMS Working Groups, CIOMS Form #pv #pharmacovigilance #themedico #themedicogirl #bpharmacy

05:14

Drug safety evaluation in special population: Paediatrics, Pregnancy and lactation, Geriatrics #pv

11:51

ICH Guidelines for PV:Org&obj,Expedited&Post approval ex reporting,ICSR,PSUR,PV plan,GCP in PV study

03:36

Pharmacogenomics of adverse drug reactions: Genetics related ADR with example focusing PK parameters

05:39

Pharmacovigilance:Safety data generation:Pre clinical phase,Clinical phase, Post approval phase(PMS)

06:03

Communication in PV:Effective com,Com in Drug Safety Crisis management,RA,Business Partners,HC&Media

07:52

Pv methods:Passive&active surveillance,Stimulated report,Comparative obs,Targeted cli in,Des studies

06:33

Vaccine safety surveillance: Vac PV, Vaccination failure, Adverse events following immunization AEFI

03:17

Establishing PV prog:in hospital,operation of drug safety department in industry, CRO, national prog

02:10

Information resources in PV: Basic drug information resources AND Specialised resources for ADRs

05:43

Drug dictionaries&coding in PV: WHO AR terms,MedDRA&SMQs,WHO drug dic,Eudravigilance med product dic

08:00

Drug &disease classification: ATC classification of drugs, International class of diseases, DDD, INN

08:20

Basic terminologies used in PV: Terminologies of medication related AEs, Regulatory terminologies

14:21

Intro to ADR: Def&class, Detect&report,causality,severe &serious asses, Predict&prevent asses,Manage

11:58

Intro toPV:His&develop,Imp of medicine safety monitoring,WHO international drug monitoring prog,PvPI

04:22

Mock fire drill in apartment|How to use fire extinguisher? #fire #firedrill #extinguisher #mockdrill

08:20

Structure of Cell: Components and its functions | What is cell |Cell types|Human Anatomy&Physiology

06:10

Introduction,scope & types of Anatomy and Physiology | Definition of various terminologies | HAP

09:08

Non-Parametric tests:Wilcoxon Rank Sum Test, Mann-Whitney U test, Kruskal-Wallis test, Friedman Test

08:40

Intro to practical component of Industrial&Clinical TrialProb:Stat Ana byExcel,SPSS,MINITAB,R-Online

04:29

Regression modeling: Hypothesis testing in Simple and Multiple regression models

04:09

Blocking and confounding system for Two-level factorials.

02:33

Box Behnken Design (BBD) | BBD versus CCD (Central Composite Design)

13:27

Response Surface methodology: Central composite design, Historical design, Optimization Techniques

07:00

Design & Analysis of experiments: Factorial Design: Def, 2^2,2^3design, Advantages of factorial des

20:11

Mol Modeling: Molecular&quantum mechanics,Energy Minimization,Conformational ana&global minima deter

22:30

SAR v/s QSAR,His&develop of QSAR,Types of physicochem parameters,experimental & theoretical approach